PriceTargets.com logo

Synergy CHC Corp. (Uplisting) - SNYR Stock Price Target and Predictions

  • Consensus Rating: Strong Buy
  • Consensus Price Target: $10.00
  • Forecasted Upside: 193.26%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 1 Strong Buy Ratings
$3.41 As of 03/6/2025 03:28 PM ET
▼ -0.13 (-3.67%)

This chart shows the closing price for SNYR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
JanFebMar$3.41Closing price on 03/06/25:
Get New Synergy CHC Corp. (Uplisting) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SNYR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SNYR

Analyst Price Target is $10.00
▲ +193.26% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Synergy CHC Corp. (Uplisting) in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 193.26% upside from the last price of $3.41.

This chart shows the closing price for SNYR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
10/2412/243/253/26$2.11$4.09$6.06$8.03$10Closing price on 03/06/25: $3.41High$10.00Average$10.00Low$10.00




Current Consensus is Strong Buy

The current consensus among 2 contributing investment analysts is to buy (strong buy) stock in Synergy CHC Corp. (Uplisting).

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/13/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/12/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/7/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/6/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/6/2025

Latest Recommendations

  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/21/2025Roth CapitalSet Target$10.00
1/21/2025Roth CapitalUpgradeStrong-Buy
1/21/2025Roth MkmInitiated CoverageBuy$10.00
(Data available from 3/6/2020 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/8/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/7/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/7/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/6/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/6/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/5/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/4/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/6/2025

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Synergy CHC Corp. (Uplisting) logo
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.
Read More

Today's Range

Now: $3.41
Low: $3.40
High: $3.78

50 Day Range

MA: $3.98
Low: $3.02
High: $4.98

52 Week Range

Now: $3.41
Low: $0.12
High: $10.00

Volume

4,911 shs

Average Volume

18,486 shs

Market Capitalization

$29.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Synergy CHC Corp. (Uplisting)?

The following Wall Street research analysts have issued research reports on Synergy CHC Corp. (Uplisting) in the last twelve months: Roth Capital, and Roth Mkm.
View the latest analyst ratings for SNYR.

What is the current price target for Synergy CHC Corp. (Uplisting)?

0 Wall Street analysts have set twelve-month price targets for Synergy CHC Corp. (Uplisting) in the last year. Their average twelve-month price target is $10.00, suggesting a possible upside of 193.3%. Roth Capital has the highest price target set, predicting SNYR will reach $10.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $10.00 for Synergy CHC Corp. (Uplisting) in the next year.
View the latest price targets for SNYR.

What is the current consensus analyst rating for Synergy CHC Corp. (Uplisting)?

Synergy CHC Corp. (Uplisting) currently has 1 buy rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Strong Buy."
View the latest ratings for SNYR.

What other companies compete with Synergy CHC Corp. (Uplisting)?

Other companies that are similar to Synergy CHC Corp. (Uplisting) include Telomir Pharmaceuticals, Cassava Sciences, Instil Bio, Tiziana Life Sciences and Sutro Biopharma. Learn More about companies similar to Synergy CHC Corp. (Uplisting).

How do I contact Synergy CHC Corp. (Uplisting)'s investor relations team?

Synergy CHC Corp. (Uplisting)'s physical mailing address is 865 Spring Street, Westbrook, ME 04092, United States. The company's listed phone number is (207) 321-2350 and its investor relations email address is snyr@gateway-grp.com. The official website for Synergy CHC Corp. (Uplisting) is synergychc.com. Learn More about contacing Synergy CHC Corp. (Uplisting) investor relations.





Receive Synergy CHC Corp. (Uplisting) News & Ratings Daily
Sign up to receive the latest news and ratings for Synergy CHC Corp. (Uplisting) and its competitors with PriceTargets.com’s free daily newsletter.